Stockscreener 앱 받기
1.23
9.82%
0.11
시간 외 거래:
1.37
0.14
+11.38%
Lunai Bioworks Inc 주식(LNAI)의 최신 뉴스
Lunai Bioworks corrects link in naked short selling lawsuit release - scanx.trade
Lunai Bioworks FY26 Results: Net loss narrows to $3.2M - scanx.trade
Lunai (LNAI) Pulls Back -3.63% From $1.95 Resistance 2026-09-29Breakout Trade - siam.in
Lunai Bioworks (LNAI) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Parkinson’s Disease Platform Advanced via Exclusive Global Agreement with Tanaist, Inc. Adding Human Cellular Phenotyping for Lunai Bioworks (Nasdaq: LNAI) - conwaydailysun.com
Parkinson's Disease Platform Advanced via Exclusive Global - openpr.com
Lunai Bioworks Inc. (LNAI) Stock Price, News, Quote & History - Yahoo! Finance Canada
Lunai Bioworks, Inc. Adds Human Cellular Phenotyping To Its Parkinson's Disease Discovery And Validation Platform And Forms LNAI Pathfinder Consortium - marketscreener.com
Lunai Bioworks Licenses Tanaist’s Cellular Phenotyping Tech to Validate Parkinson’s Findings - GenomeWeb
Lunai Bioworks secures exclusive Tanaist license for Parkinson’s By Investing.com - Investing.com Nigeria
Lunai Bioworks (LNAI) Partners with Tanaist to Advance Parkinson's Disease Research - GuruFocus
Lunai Bioworks (N A S D A Q: LNAI) Takes Parkinson's Discovery to the Next Level With Exclusive Tanaist Agreement - Carroll County Mirror-Democrat
Lunai Bioworks Inc. (LNAI) latest stock news and headlines - Yahoo Finance UK
Lunai Bioworks secures exclusive Tanaist license for Parkinson’s - Investing.com
Lunai Bioworks partners with Tanaist to enhance Parkinson's disease research using human cellular validation. - Pluang
Lunai Bioworks Expands Parkinson's Platform Through Exclusive Tanaist Agreement - TradingView
Lunai Bioworks (NASDAQ: LNAI) Expands Parkinson's Platform Through Exclusive Tanaist Agreement - Nasdaq
Why Is LNAI Stock Skyrocketing Today? - Stocktwits
Chemical-screening model finds 5.1 times more enzyme-blocking compounds - Stock Titan
Lunai Bioworks shows 5.1-fold enrichment in AI chemical risk screening - scanx.trade
Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery - Treasure Coast News
Lunai Bioworks corrects a link in its lawsuit p... - pluang.com
Lunai Bioworks (NASDAQ: LNAI) Issues Correction to Press Release Regarding Second Amended Complaint - TradingView
Lunai Bioworks files second amended complaint against six broker-dealers in Delaware - scanx.trade
Lunai Bioworks (LNAI) Surges 9% to $2.40, Testing Key Resistance at $2.52Retail Driven Moves - dars.gov.et
Lunai (LNAI) Earnings Data Review: The Company Reports Its Latest Available Figures in the Latest Reading; Closing Response: The Market Price Declines 3.78% in the Latest ReadingNet Income Trends - vinanet.vn
Lunai Bioworks Ord Shs (LNAI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Lunai Bioworks (LNAI) Slips 1.44% to $2.40 as Biotech Traders Eye Key $2.28 SupportMomentum Surge Alerts - dars.gov.et
Lunai Bioworks (LNAI) Slips 1.18% as Shares Test Key Support Near $2.39NHNL Divergence - careplusvn.com
Lunai Bioworks signs collaboration with BrainStorm Therapeutics - Investing.com
Lunai Bioworks files amended complaint alleging naked short selling - Investing.com
Lunai Bioworks signs collaboration with BrainStorm Therapeutics By Investing.com - Investing.com UK
Lunai Bioworks (Nasdaq: LNAI) Signs Definitive Collaboration Agreement With BrainStorm Therapeutics; Initial Parkinson's Disease Data Readout Targeted for First Half of 2027 - 富途牛牛
Lunai Bioworks files amended complaint alleging naked short selling By Investing.com - Investing.com India
Lunai Bioworks (Nasdaq: LNAI) Names 10 Defendants in Naked Short Selling Fraud Suit - Yahoo Finance
LNAI Q2 2026 Earnings: Biotech Posts $0.08 Per-Share Loss; Stock Retreats 3.96%Return On Capital - careplusvn.com
LNAI Q2 2026 Earnings: Reported Loss of -$0.08 Per Share as Stock Climbs 5.45%Analyst Earnings Estimate - vinanet.vn
Lunai Bioworks (LNAI) Declines 4.27%, Testing Key Support Near $1.92Unusual Put Volume - dars.gov.et
LNAI: Lunai Bioworks Inc.Financial Overview - Zacks Investment Research
Lunai Bioworks Holds Steady at $2.24: Consolidation Phase Amid Key SupportVolume Climax - careplusvn.com
LNAI|Lunai Bioworks Ord Shs|Price:2.240|Chg%:-0.090 - TradingKey
Lunai Bioworks Ord Shs (LNAI) Institutional Confidence - TradingKey
Lunai Bioworks Inc. Revenue Breakdown – NASDAQ:LNAI - TradingView
Lunai Bioworks Ord Shs (LNAI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Lunai Bioworks Ord Shs (LNAI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Lunai Bioworks(LNAI) Stock Options Chain | Quotes & News - Moomoo
Lunai Bioworks Inc. (LNAI) investor group discloses 9.41% stake in Schedule 13G - Stock Titan
Lunai Bioworks (LNAI) Tests Key Support After 3.4% DeclineTICK Divergence - careplusvn.com
LNAI Q2 2026 Earnings: Pre-Revenue Biotech Reports Loss of $0.08 Per Share; Stock Climbs 5.3 PointsROA Comparison - vinanet.vn
Lunai Bioworks Inc. (LNAI) Q2 2026 Earnings: Pre-Revenue Biotech Reports Narrowed Loss, Shares SlideEarnings Miss Streak - dars.gov.et
LNAI Q2 2026 Earnings: Biotech Reports Narrowing Loss, Shares Rise 7.1%Debt Analysis Report - dars.gov.et
5.32%
자본화:
|
볼륨(24시간):